Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

SHE:300436 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Market Capitalization	20,088	14,199	5,203	4,082	6,237	7,626
Market Cap Growth	314.90%	172.88%	27.47%	-34.55%	-18.22%	40.97%
Enterprise Value	20,399	14,474	5,570	4,394	6,256	7,352
Last Close Price	126.13	89.15	32.67	25.63	39.16	48.03
Forward PE	-	46.43	46.43	46.43	46.43	46.43
PS Ratio	48.15	34.10	11.79	9.66	16.17	20.59
PB Ratio	63.54	41.00	13.11	7.17	6.53	7.26
P/TBV Ratio	552.41	254.49	105.00	24.67	8.11	8.81
P/OCF Ratio	-	-	251.27	-	-	-
EV/Sales Ratio	48.99	34.76	12.62	10.39	16.22	19.85
EV/EBITDA Ratio	-	2216.31	-	-	-	-
Debt / Equity Ratio	1.54	1.32	1.12	0.81	0.33	0.18
Debt / EBITDA Ratio	70.98	56.54	-	-	-	-
Net Debt / Equity Ratio	0.88	0.70	0.75	0.45	0.08	-0.20
Net Debt / EBITDA Ratio	52.26	37.06	-9.89	-1.83	-0.43	7.04
Net Debt / FCF Ratio	-2.70	-2.56	-6.45	-0.68	-0.23	1.07
Asset Turnover	0.30	0.29	0.29	0.27	0.26	0.30
Inventory Turnover	1.24	1.31	1.79	2.07	2.16	2.09
Quick Ratio	0.61	0.65	0.42	0.50	0.72	1.50
Current Ratio	1.02	1.08	0.71	0.75	0.97	1.82
Return on Equity (ROE)	-70.95%	-65.09%	-35.71%	-49.17%	-14.02%	-4.19%
Return on Assets (ROA)	-3.87%	-3.78%	-5.11%	-8.53%	-9.56%	-4.13%
Return on Invested Capital (ROIC)	-14.65%	-13.39%	-16.40%	-22.88%	-24.04%	-10.80%
Return on Capital Employed (ROCE)	-9.70%	-9.30%	-14.40%	-20.90%	-20.70%	-7.10%
Earnings Yield	-1.07%	-1.53%	-3.00%	-8.54%	-2.04%	-0.46%
FCF Yield	-0.51%	-0.67%	-0.89%	-9.21%	-5.06%	-2.52%
Buyback Yield / Dilution	-0.01%	-0.00%	0.00%	-0.06%	-6.54%	-6.43%
Total Shareholder Return	-0.01%	-0.00%	0.00%	-0.06%	-6.54%	-6.43%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.